Elizabeth Reczek

Neutron Therapeutics, Inc. is a private company that specializes in providing accelerator-based boron neutron capture therapy (BNCT) systems for targeted radiation therapy of solid tumors. The company is based in Danvers, MA and was founded in 2015 by Bill Buckley and Ted Smick. The company's flagship product, the Nubeam® therapy platform, is a compact, in-hospital neutron source that offers a higher neutron flux compared to competing systems and meets stringent reference values published by the International Atomic Energy Agency. Elizabeth Reczek has been the CEO of the company since 2020.

Neutron Therapeutics, Inc. is a private company that specializes in providing accelerator-based boron neutron capture therapy (BNCT) systems for targeted radiation therapy of solid tumors. The company is based in Danvers, MA and was founded in 2015 by Bill Buckley and Ted Smick. The company's flagship product, the Nubeam® therapy platform, is a compact, in-hospital neutron source that offers a higher neutron flux compared to competing systems and meets stringent reference values published by the International Atomic Energy Agency. Elizabeth Reczek has been the CEO of the company since 2020.

Neutron Therapeutics, Inc. is a private company that specializes in providing accelerator-based boron neutron capture therapy (BNCT) systems for targeted radiation therapy of solid tumors. The company is based in Danvers, MA and was founded in 2015 by Bill Buckley and Ted Smick. The company's flagship product, the Nubeam® therapy platform, is a compact, in-hospital neutron source that offers a higher neutron flux compared to competing systems and meets stringent reference values published by the International Atomic Energy Agency. Elizabeth Reczek has been the CEO of the company since 2020.

Neutron Therapeutics, Inc. is a private company that specializes in providing accelerator-based boron neutron capture therapy (BNCT) systems for targeted radiation therapy of solid tumors. The company is based in Danvers, MA and was founded in 2015 by Bill Buckley and Ted Smick. The company's flagship product, the Nubeam® therapy platform, is a compact, in-hospital neutron source that offers a higher neutron flux compared to competing systems and meets stringent reference values published by the International Atomic Energy Agency. Elizabeth Reczek has been the CEO of the company since 2020.